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Regarding “Cost implications of more widespread
carotid artery stenting consistent with the American
College of Cardiology/American Heart Association
guideline”
The recent article by Paraskevas et al1 brings important atten-
tion to the cost implications of more widespread replacement of
carotid endarterectomy (CEA) with carotid artery stenting (CAS).
They reported charges instead of costs, and charges are difficult to
interpret in theMedicare population because cost and payment are
not the same as charges. Charges are an indicator of what the
hospital would like to be paid, but in the United States, this does
not necessarily predict what the hospital will be paid. Also, charges
are proportional to cost but are not the same as cost.
Almost simultaneous to the publishing of that article, we
published a report comparing costs and payments for carotid
endarterectomy (CEA) and carotid stenting (CAS) in asymptom-
atic Medicare patients.2 We noted that the cost of CAS was about
$5000 higher than the cost for CEA,2 which is more tangible than
a $12,000 difference in charges. The charges and cost are indeed
Dr Cloft is the Primary Investigator at an enrolling site for the SAPPHIREh
(Stenting and Angioplasty with Protection in Patients and HIghRisk for
Endarterectomy) registry sponsored by Cordis Endovascular.oth higher, but then we need to factor in the payments. The
ifference inDiagnosis-RelatedGroup payment for uncomplicated
ases is about $4000 higher for carotid stenting,2 so that is what
he government’s incremental cost would be for each Medicare
atient converted to CAS.
Because each hospital tends to lose $1300 on a CEA and
$3200 on a stent,2 the average net increase in loss to the hospitals
or each Medicare patient converted from CEA to CAS is $1900.
e can thus conclude that if an additional 50,000 patients per year
ere to be switched from CEA to CAS so that the percentages of
EA and CAS became similar (ie, 50% for CAS and 50% for CEA),
he hospitals would lose an additional $95 million each year,
espite Medicare making an additional $200 million in payments
o the hospitals. These facts further highlight the conclusion of
araskevas et al1 that diverting a large number of patients to
tenting has a huge economic impact.
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